|
|
|
|

|
Home >> Investor Relations >> Corporate Governance >> Insider Transactions
Insider Transactions
| Date |
Name |
Title |
Type  |
Shares Traded |
Price Range |
| Jun 28, 2007 |
topper james n |
Director |
Buy |
4,281 |
11.48 - 11.50 |
| Jun 29, 2007 |
topper james n |
Director |
Buy |
13,900 |
11.41 - 11.50 |
| Feb 19, 2008 |
topper james n |
Director |
Buy |
9,600 |
9.74 - 10.12 |
| Feb 15, 2008 |
topper james n |
Director |
Buy |
6,900 |
10.47 - 10.50 |
| Feb 13, 2008 |
topper james n |
Director |
Buy |
6,200 |
10.10 - 10.43 |
| Feb 13, 2008 |
topper james n |
Director |
Buy |
5,800 |
10.44 - 10.50 |
| Feb 12, 2008 |
topper james n |
Director |
Buy |
9,400 |
9.99 - 10.12 |
| Feb 11, 2008 |
topper james n |
Director |
Buy |
5,700 |
9.93 - 10.16 |
| Feb 8, 2008 |
topper james n |
Director |
Buy |
33,800 |
9.94 - 10.28 |
| Feb 6, 2008 |
topper james n |
Director |
Buy |
45,477 |
10.00 - 10.25 |
| Feb 7, 2008 |
topper james n |
Director |
Buy |
25,400 |
9.96 - 10.20 |
| Feb 27, 2008 |
topper james n |
Director |
Buy |
14,700 |
9.65 - 9.94 |
| Feb 27, 2008 |
topper james n |
Director |
Buy |
8,600 |
9.95 - 10.18 |
| Feb 28, 2008 |
topper james n |
Director |
Buy |
2,038 |
9.84 - 9.96 |
| Feb 28, 2008 |
topper james n |
Director |
Buy |
5,762 |
9.97 - 10.49 |
| Feb 26, 2008 |
topper james n |
Director |
Buy |
6,100 |
9.49 - 9.97 |
| Feb 26, 2008 |
topper james n |
Director |
Buy |
1,900 |
9.99 - 10.28 |
| Feb 20, 2008 |
topper james n |
Director |
Buy |
49,500 |
9.50 - 9.82 |
| Feb 25, 2008 |
topper james n |
Director |
Buy |
9,700 |
9.45 - 9.95 |
| Feb 21, 2008 |
topper james n |
Director |
Buy |
5,500 |
9.86 - 10.50 |
|
|
Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
|
|
|
|
|
|
|